Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Current Assets: 2010-2021

Historic Current Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $1.0 billion.

  • Neurocrine Biosciences' Current Assets fell 13.07% to $1.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 billion, marking a year-over-year decrease of 13.07%. This contributed to the annual value of $1.0 billion for FY2020, which is 22.29% up from last year.
  • Neurocrine Biosciences' Current Assets amounted to $1.0 billion in Q3 2021, which was down 9.40% from $1.1 billion recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Current Assets registered a high of $1.2 billion during Q3 2020, and its lowest value of $239.5 million during Q1 2017.
  • Its 3-year average for Current Assets is $956.4 million, with a median of $1.0 billion in 2021.
  • In the last 5 years, Neurocrine Biosciences' Current Assets plummeted by 40.28% in 2017 and then skyrocketed by 114.54% in 2018.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Current Assets stood at $554.9 million in 2017, then surged by 32.95% to $737.8 million in 2018, then climbed by 12.64% to $831.0 million in 2019, then increased by 22.29% to $1.0 billion in 2020, then fell by 13.07% to $1.0 billion in 2021.
  • Its last three reported values are $1.0 billion in Q3 2021, $1.1 billion for Q2 2021, and $1.1 billion during Q1 2021.